The Ministry of Health and Family Welfare (MoHFW) has officially launched the National Cervical Cancer Vaccination Campaign, targeting girls aged 9–14 years across India. The campaign aims to provide the Human Papillomavirus (HPV) vaccine through a school-based approach, supplemented by community outreach for out-of-school girls. The initiative utilizes CERVAVAC, India’s first indigenous quadrivalent HPV vaccine, which offers protection against four common strains of the virus responsible for cervical cancer. By integrating this vaccination into the Universal Immunization Programme (UIP), the government seeks to reduce the high burden of cervical cancer, which currently remains the second most frequent cancer among women in India.
Key Pillars of the Vaccination Campaign
Targeted Age Cohort: Focusing on girls in the 9–14 age group to ensure maximum vaccine efficacy before potential exposure to HPV.
Indigenous Vaccine Utilization: Prioritizing CERVAVAC to ensure affordability, large-scale availability, and reduced reliance on global supply chains.
School-Based Delivery Model: Leveraging the existing educational infrastructure for mass screening and immunization, ensuring high coverage rates.
Digital Tracking via U-WIN: Utilizing the U-WIN platform to maintain real-time digital records of vaccination status, ensuring timely follow-up for the second dose.
Community Awareness Initiatives: Engaging ASHAs and Anganwadi workers to educate parents and overcome vaccine hesitancy in rural and semi-urban areas.
Sustainable Financing: Providing the vaccine free of cost in government facilities to eliminate the "financial barrier" for low-income families.
What is "CERVAVAC"? CERVAVAC is India’s first indigenously developed quadrivalent Human Papillomavirus (qHPV) vaccine. It provides the mechanical framework for cervical cancer prevention by targeting HPV types 6, 11, 16, and 18, which are linked to both cervical cancer and genital warts. Developed by the Serum Institute of India, CERVAVAC ensures "Technical Fidelity" in the domestic health security architecture by providing a low-cost, high-efficacy alternative to imported vaccines.
Policy Relevance: Health Sovereignty and Human Capital
Operationalizing Preventive Healthcare: The campaign serves as a primary mechanic to shift India’s healthcare focus from "Curative" to "Preventive," reducing the long-term fiscal burden on the public health system.
Bypassing the Healthcare Access Gap: By integrating vaccination into schools and utilizing the U-WIN portal, the government is using a digital-physical hybrid model to bypass traditional infrastructure bottlenecks in remote areas.
Mechanical Link to Women’s Workforce Participation: Reducing the incidence of cervical cancer is a critical pillar for the "Viksit Bharat" vision, ensuring that health-related shocks do not hinder the long-term economic participation of women.
Indigenous Manufacturing and R&D: The successful rollout of CERVAVAC demonstrates "Implementation Fidelity" in the Atmanirbhar Bharat initiative, showcasing India's capability to develop and deploy complex biologicals at scale.
Relevant Question for Policy Stakeholders: What policy-level frameworks are required to standardize the "preventive health" messaging used by Anganwadi workers to address socio-cultural barriers to HPV vaccination?
Follow the full release here: Cervical Cancer Vaccination Campaign Launched
